|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02561 VISEN PHARMA-B
Nominal 
() | 2024/12 - Final RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (271,310) | (246,549) |
| Net Cash from / (used in) Investing Activities | -- | (520) | (1,766) |
| Net Cash from / (used in) Financing Activities | -- | (6,952) | (7,949) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (278,782) | (256,264) |
| Cash & Cash Equivalents at beginning of period | -- | 626,458 | 882,653 |
| Effect of Foreign Exchange Rate Changes | -- | 106 | 69 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 347,782 | 626,458 |
| Remarks: | Real time quote last updated: 20/03/2025 10:09 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -182,242,000 |
| %Change | -26.978% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |